Restance, Inc. (OTC: ANCE)
Breaking News - November 28, 2017
RESTANCE Announces Contract To Manufacture Playboy Condoms For Distribution In
Africa In Support Of $20 Million World AIDS Day Campaign
SPARKS, Nevada, November 28, 2017 /PRNewswire/ -- RESTANCE, Inc. (OTC:
ANCE)
today announced a contract to manufacture condoms with the Playboy brand name
and bunny head logo for distribution starting in Kenya. The brand name is being
announced today in support of World AIDS Day, coming on December 1, 2017.
RESTANCE is participating in a campaign to contribute to the United Nations goal
of ending the AIDS Epidemic by making condoms available everywhere in Africa
through the #DoIt4Africa
buy-one-give-one campaign where an anticipated $20 million in condoms will be
sold in North American and for every condom sold, a condom will be manufactured
in Africa and given away in Africa. RESTANCE
has executed an initial $500,000 contract to produce condoms for the campaign.
Look for more details on the #DoIt4Africa campaign coming soon.
In addition to opening a condom manufacturing plant, RESTANCE is pursuing
several other business lines in the growing economies of East Africa. The
Company is developing opportunities in the region including initiatives in
technology and systems integration services, utility support services,
affordable housing and health products manufacturing. RESTANCE recently acquired
East African Development Partners as part of its strategy in East Africa.
Learn more about the RESTANCE operations in Africa on the Company's website:
www.restanceinc.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the Company's current
views with respect to future events that involve risks and uncertainties. Among
others, these risks include the expectation that any of the companies mentioned
herein will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of competitive
pricing. In the light of these uncertainties, the forward-looking events
referred to in this release might not occur.
Randell Torno
ir@restanceinc.com
+1-800-834-5792
SOURCE RESTANCE, Inc.
RESTANCE and Mariah Carey Both
Support World AIDS Day - Find Out What Else They Have In Common on November 28,
2017
SPARKS, Nevada, November 22, 2017 /PRNewswire/ -- Next week, on November
28, 2017, RESTANCE, Inc. (OTC:
ANCE)
will reveal the major brand name and globally recognized label that will appear
on the condoms manufactured by RESTANCE in Africa for the #DoItForAfrica
buy-one-give-one campaign anticipated to generate $20 million in revenue. The #DoItForAfrica
campaign is designed to contribute to the United Nations goal of ending the AIDS
Epidemic. The campaign is being announced in conjunction with Worlds AIDS Day,
on December 1, 2017. RESTANCE plans to contribute to the UN goal to end the AIDS
Epidemic by making condoms available everywhere in Africa through the #DoItForAfrica
buy-one-give-one campaign where an anticipated $20 million in condoms will be
sold in North American and for every condom sold, a condom will be manufactured
in Africa and given away in Africa. RESTANCE has executed an initial $500,000
contract to produce
condoms for the campaign.
What Do Mariah Carey and RESTANCE Have In Common?
Both Mariah Carey and RESTANCE support World AIDS Day. To commemorate World AIDS
Day on December 1st and celebrate its 30th anniversary, AIDS Healthcare
Foundation (AHF), Grammy award-winning singer Mariah Carey and award-winning
music producer DJ Khaled will perform at a free concert event hosted by Mario
Lopez and actress Laverne Cox on November 30th at the Shrine Auditorium in Los
Angeles, located at 665 W. Jefferson Blvd. Debbie Allen and the Debbie Allen
Dance Academy will also perform during the event.
On November 28, 2017, when RESTANCE reveals the major brand name and globally
recognized label that will appear on the condoms manufactured by RESTANCE in
Africa for the #DoItForAfrica buy-one-give-one campaign, find out what else,
Mariah Carey and RESTANCE have in common.
RESTANCE - $20 Million Revenue #DoItForAfrica Campaign
RESTANCE has acquired the tools to equip a condom manufacturing plant and plans
to open a condom manufacturing plant in Kenya soon to produce condoms for all
Africa. RESTANCE has secured a contract where the company will produce condoms
under a major, globally recognized brand name in conjunction with the #DoItForAfrica
buy-one-give-one campaign. The #DoItForAfrica campaign is anticipated to
generate $20 million in revenue.
RESTANCE is pursuing several business lines in the growing economies of East
Africa. The Company is developing opportunities in the region including
initiatives in technology and systems integration services, utility support
services, affordable housing and health products manufacturing. RESTANCE
recently acquired East African Development Partners as part of its strategy in
East Africa.
Learn more about the RESTANCE operations in Africa on the Company's website:
http://www.restanceinc.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the Company's current
views with respect to future events that involve risks and uncertainties. Among
others, these risks include the expectation that any of the companies mentioned
herein will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of competitive
pricing. In the light of these uncertainties, the forward-looking events
referred to in this release might not occur.
Randell Torno
ir@restanceinc.com
+1-800-834-5792
SOURCE RESTANCE, Inc.
RESTANCE to Reveal Major Brand
Name and Globally Recognized Logo to go on Condoms Manufactured in Campaign to
End AIDS
SPARKS, Nevada, November 21, 2017 /PRNewswire/ -- RESTANCE, Inc. (OTC:
ANCE)
today announced the company plans to reveal next week the major brand name and
globally recognized logo that will appear on the condoms manufactured by
RESTANCE in Africa for the #DoItForAfrica buy-one-give-one campaign anticipated
to generate $20 million in revenue. Yesterday, the company announced a $500,000
contract to manufacture condoms under a major brand name for distribution in
Africa. The company plans to reveal the "major brand name" on November 28, 2017
in conjunction with a World AIDS Day announcement. The $500,000 contract is part
of a strategic campaign that will be announced on November 28, 2017 in
conjunction with World AIDS Day on December 1, 2017. The campaign is designed to
contribute to the United Nations goal of ending the AIDS Epidemic. RESTANCE
plans to contribute to the UN goal to end the AIDS Epidemic by making condoms
available everywhere in Africa through the #DoItForAfrica buy-one-give-one
campaign where an anticipated $20 million in condoms will be sold in North
American and for every condom sold, a condom will be manufactured in Africa and
given away in Africa. The contract announced today is the initial commitment for
the condoms to be
manufactured and given away in Africa.
RESTANCE - $20 Million Revenue #DoItForAfrica Campaign
RESTANCE has acquired the tools to equip a condom manufacturing plant and plans
to open a condom manufacturing plant in Kenya soon to produce condoms for all
Africa. RESTANCE has secured a contract where the company will produce condoms
under a major, globally recognized brand name in conjunction with the #DoItForAfrica
buy-one-give-one campaign. The #DoItForAfrica campaign is anticipated to
generate $20 million in revenue.
RESTANCE is pursuing several business lines in the growing economies of East
Africa. The Company is developing opportunities in the region including
initiatives in technology and systems integration services, utility support
services, affordable housing and health products manufacturing. RESTANCE
recently acquired East African Development Partners as part of its strategy in
East Africa.
Learn more about the RESTANCE operations in Africa on the Company's website:
http://www.restanceinc.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the Company's current
views with respect to future events that involve risks and uncertainties. Among
others, these risks include the expectation that any of the companies mentioned
herein will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of competitive
pricing. In the light of these uncertainties, the forward-looking events
referred to in this release might not occur.
Randell Torno
ir@restanceinc.com
+1-800-834-5792
SOURCE RESTANCE, Inc.
RESTANCE Announces $500,000
Contract to Manufacture Brand Name Condoms for Distribution in Africa as Part of
Campaign to end AIDS Epidemic
SPARKS, Nevada, November 20, 2017 /PRNewswire/ -- RESTANCE, Inc. (OTC:
ANCE)
today announced a $500,000 contract to manufacture condoms under a major brand
name for distribution in Africa. The company plans to reveal the 'major brand
name' on November 28, 2017 in conjunction with a World AIDS Day announcement.
The $500,000 contract is part of a strategic campaign that will be announced on
November 28, 2017 in conjunction with World AIDS Day on December 1, 2017. The
campaign is designed to contribute to the United Nations' goal of ending the
AIDS Epidemic. RESTANCE plans to contribute to the UN goal to end the AIDS
Epidemic by making condoms available everywhere in Africa through the previously
announced #DoItForAfrica buy-one-give-one campaign where an anticipated $20
million in condoms will be sold in North American and for every condom sold, a
condom will be manufactured in Africa and will be given away in Africa. The
contract announced today is the initial commitment for the condoms to be
manufactured and given away in Africa.
RESTANCE - $20 Million Revenue #DoItForAfrica Campaign
RESTANCE has acquired the tools to equip a condom manufacturing plant and plans
to open a condom manufacturing plant in Kenya soon to produce condoms for all
Africa. RESTANCE has secured a contract where the company will produce condoms
under a major, globally recognized brand name in conjunction with the #DoItForAfrica
buy-one-give-one campaign. The #DoItForAfrica campaign is anticipated to
generate $20 million in revenue.
RESTANCE is pursuing several business lines in the growing economies of East
Africa. The Company is developing opportunities in the region including
initiatives in technology and systems integration services, utility support
services, affordable housing and health products manufacturing. RESTANCE
recently acquired East African Development Partners as part of its strategy in
East Africa.
Learn more about the RESTANCE operations in Africa on the Company's website:
http://www.restanceinc.com.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the Company's current
views with respect to future events that involve risks and uncertainties. Among
others, these risks include the expectation that any of the companies mentioned
herein will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of competitive
pricing. In the light of these uncertainties, the forward-looking events
referred to in this release might not occur.
Media Contact:
Randell Torno
ir@restanceinc.com
+1-800-834-5792
SOURCE RESTANCE, Inc.
RESTANCE to Use $9 Billion
Market Momentum in Strategy to Help End Aids Epidemic
SPARKS, Nevada, November 14, 2017 /PRNewswire/ -- RESTANCE, Inc. (OTC:
ANCE)
today announced plans to introduce a strategic marketing campaign on December 1,
2017 in conjunction with World Aids Day. The campaign is designed to contribute
to the United Nations goal of ending the AIDS Epidemic. RESTANCE plans to
contribute to the UN goal to end the AIDS Epidemic by making condoms available
everywhere in Africa through the previously announced #DoItForAfrica
buy-one-give-one campaign where an anticipated $20 million in condoms will be
sold in North American and for every condom sold, a condom will be manufactured
in Africa and given away in Africa.
RESTANCE - $20 Million Revenue #DoItForAfrica Campaign
RESTANCE has acquired the tools to equip a condom manufacturing plant and plans
to open a condom manufacturing plant in Kenya soon to produce condoms for all
Africa. RESTANCE has secured a contract where the company will produce condoms
under a major, globally recognized brand name in conjunction with the #DoItForAfrica
buy-one-give-one campaign. The #DoItForAfrica campaign is anticipated to
generate $20 million in revenue. The company plans to announce the brand name
contract in conjunction with World Aids Day on December 1, 2017.
RESTANCE is pursuing several business lines in the growing economies of East
Africa. The Company is developing opportunities in the region including
initiatives in technology and systems integration services, utility support
services, affordable housing and health products manufacturing. RESTANCE
recently acquired East African Development Partners as part of its strategy in
East Africa.
Learn more about the RESTANCE operations in Africa on the Company's website:
http://www.restanceinc.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the Company's current
views with respect to future events that involve risks and uncertainties. Among
others, these risks include the expectation that any of the companies mentioned
herein will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of competitive
pricing. In the light of these uncertainties, the forward-looking events
referred to in this release might not occur.
UNAIDS World Aids Day Campaign - My Health, My Right
Learn more about the UN goals to end the World Aids Epidemic and the UNAIDS 2017
World Aids Day Campaign - My Health, My Right:http://www.UNAIDS.org
Or Contact:
UNAIDS Geneva
Sophie Barton-Knott
tel. +41-22-791-1697
bartonknotts@unaids.org
Media Contact:
Randell Torno
ir@restanceinc.com
+1-800-834-5792
SOURCE RESTANCE, Inc.
RESTANCE Highlights #DoItForAfrica
Campaign Anticipated to Generate $20 Million in Annual Sales
SPARKS, Nevada, October 27, 2017 /PRNewswire/ -- RESTANCE, Inc. (OTC:
ANCE)
today announced publishing highlights on the company's website for the upcoming
buy-one-give-one #DoItForAfrica campaign anticipated to generate $20 million in
annual sales and contribute to the United Nations goal of eliminating the spread
of AIDS in Africa. RESTANCE has acquired the tools to equip a condom
manufacturing plant and plans to open a condom manufacturing plant in Kenya soon
to produce condoms for all Africa.
RESTANCE is pursuing several business lines in the growing economies of East
Africa. The Company is developing opportunities in the region including
initiatives in technology and systems integration services, utility support
services, affordable housing and health products manufacturing. RESTANCE
recently acquired East African Development Partners as part of its strategy in
East Africa.
Learn more about the RESTANCE operations in Africa on the Company's website:
http://www.restanceinc.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the Company's current
views with respect to future events that involve risks and uncertainties. Among
others, these risks include the expectation that any of the companies mentioned
herein will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of competitive
pricing. In the light of these uncertainties, the forward-looking events
referred to in this release might not occur.
Randell Torno
ir@restanceinc.com
+1-800-834-5792
SOURCE RESTANCE, Inc.
-------------------------------------------------------------------
About Restance, Inc.:
RESTANCE, Inc. (ANCE) recently announced plans to open a condom manufacturing
plant in Kenya to produce condoms for all Africa. Research and Markets reports
the global condom market is expected to reach US $9.6 Billion by 2021 at a CAGR
of 8.2%. The United Nations reports that condom usage in Africa is growing and
is expected to continue growing until 2030. RESTANCE has already acquired the
tools to equip a manufacturing plant and is in negotiations to manufacture and
distribute for a major global brand name. CEO Randell Torno met recently with
the Kenyan Ambassador to the United Sates, H.E. Robinson Githae to discuss
investment in Kenya.
The condom manufacturing capacity is the first major step in just one component
of RESTANCE's strategy to pursue several business lines in the growing economies
of East Africa. The Company is developing opportunities in the region including
initiatives in technology and systems integration services, utility support
services, affordable housing and health products manufacturing. RESTANCE
recently acquired East African Development Partners to pursue its strategy in
East Africa.
Socially
Responsible and Fun Buy-One-Give-One Campaign
The Socially Responsible and Fun Buy-One-Give-One campaign for selling condoms
in North America and giving a way a condom in Africa for every condom sold has
been in the works for some time now. The campaign will be structured as a
crowd-sale. The campaign will be positioned as a movement encouraging consumers
to join in an effort to end the spread of sexually transmitted infection by
practicing safe-sex and contributing to the practice of safe-sex in developing
economic regions were economics are not conducive to safe-sex practices.
The Buy-One-Give-One campaign has been designed in conjunction with The United
Nations World Health Organization 2021 vision and goal for ending sexually
transmitted infections.
VISION:
Zero new infections, zero sexually transmitted infection-related complications
and deaths, and zero discrimination in a world where everybody has free and easy
access to sexually transmitted infection prevention and treatment services,
resulting in people able to live long and healthy lives.
GOAL:
Ending sexually transmitted infection epidemics as major public health concerns.
Buy-One-Give-One US$20 Million First Year Forecast
The global condoms market is over US$9 billion annually, with 27 billion units
sold largely in emerging economies of Asia, Middle East and Africa, according to
research from Global Industry Analysts. In addition to the Buy-One-Give-One
campaign, RESTANCE and its partners will also market condoms for sale throughout
Africa under a major brand name. The first year sales forecast after launching
operation is an anticipated US$20 million
On June 1, 2017 the Company entered into a share exchange agreement to purchase
100% of the shares of East African Development Partners LLC in exchange for 5
million shares of Restance, Inc. The Company is pursuing several business lines
in the growing economies of East Africa. The Company is developing opportunities
in the region including initiatives in technology and systems integration
services, utility support services, affordable housing and health products
manufacturing. The Company owns a majority interest in manufacturing equipment
being integrated into a health products manufacturing facility currently under
development.
SOURCE: http://restanceinc.com/
Disclaimer
FN Media Group LLC (FNMG) owns and operates
FinancialNewsMedia.com (FNM)
which is a third party publisher that disseminates electronic information
through multiple online media channels. FNMG's intended purposes are to deliver
market updates and news alerts issued from private and publicly trading
companies as well as providing coverage and increased awareness for companies
that issue press to the public via online newswires. FNMG and its affiliated
companies are a news dissemination and financial marketing solutions provider
and are NOT a registered broker/dealer/analyst/adviser, holds no investment
licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's
market updates, news alerts and corporate profiles are NOT a solicitation or
recommendation to buy, sell or hold securities. The material in this release is
intended to be strictly informational and is NEVER to be construed or
interpreted as research material. All readers are strongly urged to perform
research and due diligence on their own and consult a licensed financial
professional before considering any level of investing in stocks. The companies
that are discussed in this release may or may not have approved the statements
made in this release. Information in this release is derived from a variety of
sources that may or may not include the referenced company's publicly
disseminated information. The accuracy or completeness of the information is not
warranted and is only as reliable as the sources from which it was obtained.
While this information is believed to be reliable, such reliability cannot be
guaranteed. FNMG disclaims any and all liability as to the completeness or
accuracy of the information contained and any omissions of material fact in this
release. This release may contain technical inaccuracies or typographical
errors. It is strongly recommended that any purchase or sale decision be
discussed with a financial adviser, or a broker-dealer, or a member of any
financial regulatory bodies. Investment in the securities of the companies
discussed in this release is highly speculative and carries a high degree of
risk. FNMG is not liable for any investment decisions by its readers or
subscribers. Investors are cautioned that they may lose all or a portion of
their investment when investing in stocks. This release is not without bias, and
is considered a conflict of interest if compensation has been received by FNMG
for its dissemination. To comply with Section 17(b) of the Securities Act of
1933, FNMG shall always disclose any compensation it has received, or expects to
receive in the future, for the dissemination of the information found herein on
behalf of one or more of the companies mentioned in this release. For current
services performed FNMG has been compensated forty-four hundred dollars for
Restance, Inc. coverage by
a non-affiliated third party. FNMG HOLDS NO SHARES OF Restance, Inc.
This release contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the Securities
Exchange Act of 1934, as amended and such forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words such as "may",
"future", "plan" or "planned", "will" or "should", "expected," "anticipates",
"draft", "eventually" or "projected". You are cautioned that such statements are
subject to a multitude of risks and uncertainties that could cause future
circumstances, events, or results to differ materially from those projected in
the forward-looking statements, including the risks that actual results may
differ materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a company's annual
report on Form 10-K or 10-KSB and other filings made by such company with the
Securities and Exchange Commission. You should consider these factors in
evaluating the forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this release are
made as of the date hereof and FNMG undertakes no obligation to update such
statements.
|
